Advances in Cancer Immunotherapy™️ Webinar: Clinical Updates from ASCO20 Virtual

When:  Sep 10, 2020 from 17:00 to 18:00 (ET)
On September 10, 2020 join leading experts in cancer immunotherapy as they discuss the latest advances in cancer immunotherapy emerging from ASCO20 Virtual. This is a FREE CME-, CNE-, CPE- and MOC- certified webinar intended for clinical oncologists, registered nurses, nurse practitioners, advanced practice registered nurses, pharmacists, physician assistants, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. To view full accreditation information, click here.

Click here to register for this webinar.

Webinar Faculty
  • Michael Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center
  • Shailender Bhatia, MD – University of Washington
  • Stephan Grupp, MD, PhD – University of Pennsylvania
  • Jose Lutzky, MD, FACP – University of Miami Sylvester Cancer Center

Webinar Agenda:
5:00–5:05 p.m. EDT Overview: Welcome and Introductions
5:05–5:40 p.m. EDT Presentation
5:40–5:55 p.m. EDT Question and Answer Session
5:55–6:00 p.m. EDT Closing Remarks

Continuing Education Credit Information:
Continuing Education Credits are available for physicians, nurses, and pharmacists. To view full accreditation information, click here.

Postgraduate Institute for MedicineSITC Logo

The 2019–2020 ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.


The 2019–2020 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Celgene Corporation, Exelixis, Inc., Genentech, Incyte Corporation and Merck & Co., Inc.